Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents.
Menzies
Dhananjai J
DJ
Divisions of Cardiology and Infectious Disease, Winthrop-University Hospital, Mineola, New York 11501, USA.
Dorsainvil
Pierre A
PA
Cunha
Burke A
BA
Johnson
Diane H
DH
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy*; D004347:Drug Interactions; D005260:Female; D024841:Fluoroquinolones; D005500:Follow-Up Studies; D000077734:Gatifloxacin; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis / Q000209:etiology*; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D018570:Risk Assessment
D000890:Anti-Infective Agents; D001786:Blood Glucose; D024841:Fluoroquinolones; D007004:Hypoglycemic Agents; D000077734:Gatifloxacin